The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages

Genome Research

Volumn 24, Issue 3, 2014, Pages 377-389

  Hassan, Musa A ^a   Butty, Vincent ^a   Jensen, Kirk D C ^a   Saeij, Jeroen P J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CD123 ANTIGEN; DECTIN 1; ISOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CHROMOSOME 5; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; FEMALE; GENETIC MARKER; GENETIC VARIABILITY; LINKAGE ANALYSIS; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS MAPPING; RNA SEQUENCE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; TOXOPLASMA;

ALTERNATIVE SPLICING; ANIMALS; CYTIDINE DEAMINASE; CYTOSINE; GENETIC LINKAGE; GENETIC VARIATION; GENOME; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED C57BL; QUANTITATIVE TRAIT LOCI; RNA EDITING; RNA ISOFORMS; TOXOPLASMA; URACIL;

EID: 84895515619     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.166033.113     Document Type: Article

References (99)

1. Ahn SH, Deshmukh H, Johnson N, Cowell LG, Rude TH, Scott WK, Nelson CL, Zaas AK, Marchuk DA, Keum S, et al. 2010. Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses. PLoS Pathog 6: e1001088.
2. Anant S, Davidson NO. 2000. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: Binding of Apobec-1 to this motif in the 39 untranslated region of c-myc increases mRNA stability. Mol Cell Biol 20: 1982-1992.
3. Athanasiadis A, Rich A, Maas S. 2004.Widespread A-to-I RNA editing of Alucontaining mRNAs in the human transcriptome. PLoS Biol 2: 2144-2158.
4. Bahn JH, Lee JH, Li G, Greer C, Peng GD, Xiao XS. 2012. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res 22: 142-150.
5. Benne R, Vandenburg J, Brakenhoff JPJ, Sloof P, Vanboom JH, Tromp MC. 1986. Major transcript of the frameshifted Coxll gene from trypanosome mitochondria contains 4 nucleotides that are not encoded in the DNA. Cell 46: 819-826.
6. Boyle AE, Gill K. 2001. Sensitivity of AXB/BXA recombinant inbred lines of mice to the locomotor activating effects of cocaine: A quantitative trait loci analysis. Pharmacogenetics 11: 255-264.
7. Braunschweig U, Gueroussov S, Plocik AM, Graveley BR, Blencowe BJ. 2013. Dynamic integration of splicing within gene regulatory pathways. Cell 152: 1252-1269.
8. Broman KW, Wu H, Sen S, Churchill GA. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
9. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, et al. 2013. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494: 366-370.
10. Burrage LC, Baskin-Hill AE, Sinasac DS, Singer JB, Croniger CM, Kirby A, Kulbokas EJ, Daly MJ, Lander ES, Broman KW, et al. 2010. Genetic resistance to diet-induced obesity in chromosome substitution strains of mice. Mamm Genome 21: 115-129.
11. Caceres JF, Kornblihtt AR. 2002. Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet 18: 186-193.
12. Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat Rev Genet 3: 285-298.
13. Chen CX, Cho DSC,Wang QD, Lai F, Carter KC, Nishikura K. 2000. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6: 755-767.
14. Churchill GA, Doerge RW. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
15. Cogen AL, Moore TA. 2009. b2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia. Infect Immun 77: 360-366.
16. Danecek P, Nellaker C, McIntyre RE, Buendia-Buendia JE, Bumpstead S, Ponting CP, Flint J, Durbin R, Keane TM, Adams DJ. 2012. High levels of RNA-editing site conservation amongst 15 laboratory mouse strains. Genome Biol 13: 26.
17. David CJ, Chen M, Assanah M, Canoll P, Manley JL. 2010. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463: 364-368.
18. Degner JF, Marioni JC, Pai AA, Pickrell JK, Nkadori E, Gilad Y, Pritchard JK. 2009. Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data. Bioinformatics 25: 3207-3212.
19. Desterro JM, Keegan LP, Jaffray E, Hay RT, O'Connell MA, Carmo-FonsecaM. 2005. SUMO-1 modification alters ADAR1 editing activity. Mol Biol Cell 16: 5115-5126.
20. Dhir A, Buratti E. 2010. Alternative splicing: Role of pseudoexons in human disease and potential therapeutic strategies. FEBS J 277: 841-855.
21. Doria M, Neri F, Gallo A, Farace MG, Michienzi A. 2009. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res 37: 5848-5858.
22. Fritz EL, Rosenberg BR, Lay K, Mihailovic A, Tuschl T, Papavasiliou FN. 2013. A comprehensive analysis of the effects of the deaminase AID on the transcriptome and methylome of activated B cells. Nat Immunol 14: 749-755.
23. Gao Z, Cooper TA. 2013. Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy. Proc Natl Acad Sci 110: 13570-13575.
24. Garncarz W, Tariq A, Handl C, Pusch O, Jantsch MF. 2013. A highthroughput screen to identify enhancers of ADAR-mediated RNAediting. RNA Biol 10: 192-204.
25. Gee P, Ando Y, Kitayama H, Yamamoto SP, Kanemura Y, Ebina H, Kawaguchi Y, Koyanagi Y. 2011. APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis. J Virol 85: 9726-9736.
26. Gelfman S, Cohen N, Yearim A, Ast G. 2013. DNA-methylation effect on cotranscriptional splicing is dependent on GC architecture of the exonintron structure. Genome Res 23: 789-799.
27. GrayMW. 2012. Evolutionary origin of RNA editing. Biochemistry 51: 5235-5242.
28. Greeve J, Jona VK, Chowdhury NR, Horwitz MS, Chowdhury Jr. 1996. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable hyperlipidemic rabbits. J Lipid Res 37: 2001-2017.
29. Hamilton CE, Papavasiliou FN, Rosenberg BR. 2010. Diverse functions for DNA and RNA editing in the immune system. RNA Biol 7: 220-228.
30. Han H, Irimia M, Ross PJ, Sung HK, Alipanahi B, David L, Golipour A, Gabut M, Michael IP, Nachman EN, et al. 2013. MBNL proteins repress ES-cellspecific alternative splicing and reprogramming. Nature 498: 241-245.
31. Hartner JC, Walkley CR, Lu J, Orkin SH. 2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 10: 109-115.
32. Heinzen EL, Ge DL, Cronin KD, Maia JM, Shianna KV, Gabriel WN, Welsh- Bohmer KA, Hulette CM, Denny TN, Goldstein DB. 2008. Tissue-specific genetic control of splicing: Implications for the study of complex traits.PLoS Biol 6: 2869-2879.
33. Hoque M, Ji Z, Zheng D, LuoW, LiW, You B, Park JY, Yehia G, Tian B. 2013. Analysis of alternative cleavage and polyadenylation by 39 region extraction and deep sequencing. Nat Methods 10: 133-139.
34. Ichihara M, Hara T, Takagi M, Cho LC, Gorman DM, Miyajima A. 1995. Impaired interleukin-3 (Il-3) response of the a/Jmouse is caused by a branch point deletion in the Il-3 receptor-a subunit gene. EMBO J 14: 939-950.
35. Irimia M, Blencowe BJ. 2012. Alternative splicing: Decoding an expansive regulatory layer. Curr Opin Cell Biol 24: 323-332.
36. Jacobs MM, Fogg RL, Emeson RB, Stanwood GD. 2009. ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci 31: 223-237.
37. Jiang Q, Crews LA, Barrett CL, Chun HJ, Court AC, Isquith JM, Zipeto MA, Goff DJ, Minden M, Sadarangani A, et al. 2013. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc Natl Acad Sci 110: 1041-1046.
38. Jimenez-AMD, Viriyakosol S,Walls L, Datta SK, Kirkland T, Heinsbroek SEM, Brown G, Fierer J. 2008. Susceptibility to Coccidioides species in C57BL/6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a). Genes Immun 9: 338-348.
39. Katz Y, Wang ET, Airoldi EM, Burge CB. 2010. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7: 1009-1015.
40. Kim DDY, Kim TTY, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A. 2004.Widespread RNA editing of embedded Alu elements in the human transcriptome. Genome Res 14: 1719-1725.
41. + T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12: 984-992.
42. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. 2012. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22: 568-576.
43. Kornblihtt AR, Schor IE, Allo M, Dujardin G, Petrillo E, Munoz MJ. 2013. Alternative splicing: A pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol 14: 153-165.
44. Krisko JF, Martinez-Torres F, Foster JL, Garcia JV. 2013. HIV restriction by APOBEC3 in humanized mice. PLoS Pathog 9.
45. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
46. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, et al. 2010. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832-838.
47. Laurencikiene J, Kallman AM, Fong N, Bentley DL, Ohman M. 2006. RNA editing and alternative splicing: The importance of co-transcriptional coordination. EMBO Rep 7: 303-307.
48. Lee RM, Hirano K, Anant S, Baunoch D, Davidson NO. 1998. An alternatively spliced form of apobec-1 messenger RNA is overexpressed in human colon cancer. Gastroenterology 115: 1096-1103.
49. Lee Y, Gamazon ER, Rebman E, Lee S, Dolan ME, Cox NJ, Lussier YA. 2012. Variants affecting exon skipping contribute to complex traits. PLoS Genet 8: e1002998.
50. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, et al. 2004. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 22: 1001-1005.
51. Li H. 2011. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27: 2987-2993.
52. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map (SAM) format and SAMtools. Bioinformatics 25: 2078-2079.
53. Li MY, Wang IX, Li Y, Bruzel A, Richards AL, Toung JM, Cheung VG. 2011. Widespread RNA and DNA sequence differences in the human transcriptome. Science 333: 53-58.
54. Li J, Hakata Y, Takeda E, Liu QP, Iwatani Y, Kozak CA, Miyazawa M. 2012. Two genetic determinants acquired late in Mus evolution regulate the inclusion of exon 5, which alters mouse APOBEC3 translation efficiency. PLoS Pathog 8: e1002478.
55. Malousi A, Kouidou S. 2012. DNA hypermethylation of alternatively spliced and repeat sequences in humans. Mol Genet Genomics 287: 631-642.
56. Marshall JD, Mu JL, Cheah YC, Nesbitt MN, Frankel WN, Paigen B. 1992. The AXB and BXA set of recombinant inbred mouse strains. Mamm Genome 3: 669-680.
57. Matesic LE, De Maio A, Reeves RH. 1999. Mapping lipopolysaccharide response loci in mice using recombinant inbred and congenic strains. Genomics 62: 34-41.
58. McLeod R, Skamene E, Brown CR, Eisenhauer PB, Mack DG. 1989. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A × B/B × A recombinant inbred and B10 congenic mice. J Immunol 143: 3031-3034.
59. Medina MW, Krauss RM. 2009. The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med 19: 173-177.
60. Mehrabian M, Allayee H, Stockton J, Lum PY, Drake TA, Castellani LW, Suh M, Armour C, Edwards S, Lamb J, et al. 2005. Integrating genotypic and expression data in a segregating mouse population to identify 5- lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet 37: 1224-1233.
61. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M. 1996. A mammalian RNA editing enzyme. Nature 379: 460-464.
62. Mitrpant C, Adams AM, Meloni PL, Muntoni F, Fletcher S,Wilton SD. 2009. Rational design of antisense oligomers to induce dystrophin exon skipping. Mol Ther 17: 1418-1426.
63. Mu JL, Naggert JK, Nishina PM, Cheah YC, Paigen B. 1993. Strain distribution pattern in AXB and BXA recombinant inbred strains for loci on murine chromosomes 10, 13, 17, and 18. Mamm Genome 4: 148-152.
64. Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, Hod E, Katz A, Isaacs WB, Hebbring S, Komiya A, et al. 2005. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65: 1213-1222.
65. Navaratnam N, Bhattacharya S, Fujino T, Patel D, Jarmuz AL, Scott J. 1995. Evolutionary origins of apoB mRNA editing: Catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 81: 187-195.
66. Nesbitt MN, Skamene E. 1984. Recombinant inbred mouse strains derived from A/J and C57BL/6J: A tool for the study of genetic mechanisms in host resistance to infection and malignancy. J Leukoc Biol 36: 357-364.
67. Niewiadomska AM, Yu XF. 2009. Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif. Curr Top Microbiol 339: 1-25.
68. Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79: 321-349.
69. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57: 65-73.
70. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS. 1998. Reversal of dietinduced obesity and diabetes inC57BL/6J mice. Metabolism47: 1089-1096.
71. Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, Rangel ZG, Munson PJ, Wahl SM. 2007. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110: 393-400.
72. Quinlan AR, Hall IM. 2010. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26: 841-842.
73. Rabinovici R, Kabir K, Chen MH, Su YJ, Zhang DX, Luo XX, Yang JH. 2001. ADAR1 is involved in the development of microvascular lung injury. Circ Res 88: 1066-1071.
74. Ramaswami G, Zhang R, Piskol R, Keegan LP, Deng P, O'Connell MA, Li JB. 2013. Identifying RNA editing sites using RNA sequencing data alone. Nat Methods 10: 128-132.
75. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, et al. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 45: 970-976.
76. Rodriguez J, Menet JS, Rosbash M. 2012. Nascent-seq indicates widespread cotranscriptional RNA editing in Drosophila. Mol Cell 47: 27-37.
77. Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN. 2011. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNAediting targets in transcript 39 UTRs. Nat Struct Mol Biol 18: 230-236.
78. Rueter SM, Dawson TR, Emeson RB. 1999. Regulation of alternative splicing by RNA editing. Nature 399: 75-80.
79. Sampson SB, Higgins DC, Elliot RW, Taylor BA, Lueders KK, Koza RA, Paigen B. 1998. An edited linkage map for the AXB and BXA recombinant inbred mouse strains. Mamm Genome 9: 688-694.
80. Silva GK, Cunha LD, Horta CV, Silva ALN, Gutierrez FRS, Silva JS, Zamboni DS. 2013. A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo. PLoS ONE 8: e56347.
81. Solomon O, Oren S, Safran M, Deshet-Unger N, Akiva P, Jacob-Hirsch J, Cesarkas K, Kabesa R, Amariglio N, Unger R, et al. 2013. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR). RNA 19: 591-604.
82. Stier MT, Spindler KR. 2012. Polymorphisms in Ly6 genes in Msq1 encoding susceptibility to mouse adenovirus type 1. Mamm Genome 23: 250-258.
83. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci 100: 9440-9445.
84. Surwit RS, Kuhn CM, Cochrane C, Mccubbin JA, Feinglos MN. 1988. Dietinduced type-II diabetes in C57bl/6j mice. Diabetes 37: 1163-1167.
85. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, RebuffescriveM. 1995. Differential-effects of fat and sucrose on the development of obesity and diabetes in C57bl/6j and a/J mice. Metabolism 44: 645-651.
86. Teng B, Blumenthal S, Forte T, Navaratnam N, Scott J, Gotto AM Jr, Chan L. 1994. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNAediting protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem 269: 29395-29404.
87. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: Discovering splice junctions with RNA-seq. Bioinformatics 25: 1105-1111.
88. Tu ZD, Keller MP, Zhang CS, Rabaglia ME, Greenawalt DM, Yang X, WangIM, Dai HY, Bruss MD, Lum PY, et al. 2012. Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets. PLoS Genet 8: e1003107.
89. Valente L, Nishikura K. 2005. ADAR gene family and A-to-I RNA editing: Diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res 79: 299-338.
90. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, et al. 2009. Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 16: 670-698.
91. Wahlstedt H, Daniel C, Enstero M, Ohman M. 2009. Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res 19: 978-986.
92. Wang ZF, Burge CB. 2008. Splicing regulation: From a parts list of regulatory elements to an integrated splicing code. RNA 14: 802-813.
93. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
94. Welbourn S, Miyagi E, White TE, Diaz-Griffero F, Strebel K. 2012. Identification and characterization of naturally occurring splice variants of SAMHD1. Retrovirology 9: 86.
95. Williams RW, Gu J, Qi S, Lu L. 2001. The genetic structure of recombinant inbred mice: High-resolution consensus maps for complex trait analysis. Genome Biol 2: RESEARCH0046.
96. Winter J, Roepcke S, Krause S, Muller EC, Otto A, Vingron M, Schweiger S. 2008. Comparative 39 UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines. PLoS ONE 3: e2780.
97. Yee NK, Hamerman JA. 2013. b2 integrins inhibit TLR responses by regulating NF-kB pathway and p38 MAPK activation. Eur J Immunol 43: 779-792.
98. Yu L, Gao YF, Li X, Qiao ZP, Shen JL. 2009. Double-stranded RNA specific to adenosine kinase and hypoxanthine-xanthine-guaninephosphoribosyltransferase retards growth of Toxoplasma gondii. Parasitol Res 104: 377-383.
99. Zaphiropoulos PG. 2012. Genetic variations and alternative splicing: The glioma associated oncogene 1, GLI1. Front Genet 3: 119.